991-P: High Treatment Satisfaction with 3-Day Insulin Patch Is Independent of Patient Demographics

This post-hoc analysis explores whether high treatment satisfaction seen with a 3-day wearable patch for mealtime insulin subcutaneous delivery is applicable across different patient groups. The randomized multi-country study of adults (n=278, age: 59.2±8.9 years) with type 2 diabetes transitioned patients from basal-only to basal plus mealtime insulin therapy using one of two methods of mealtime insulin delivery. Patients were randomized 1:1 to deliver mealtime insulin using either a 3-day insulin patch or an insulin pen. Published data demonstrated that basal plus mealtime insulin therapy using either device similarly reduced A1C (1.7% patch, 1.6% pen). However, patients were more satisfied with patch than pen (Overall Satisfaction, Insulin Delivery System Rating Questionnaire (IDSRQ) p